Novel Gallium Imaging in Hepatocellular Carcinoma
NCT03116945
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
68Gallium Citrate
Sponsor
Rutgers, The State University of New Jersey
Collaborators
[object Object]